A recent study’s findings highlight some variables associated with poor surveillance adherence among melanoma survivors that could help to guide efforts in counseling this at-risk population. Researchers retrospectively reviewed the initial 5-year dermatology follow-up visit frequencies of melanoma patients and extracted basic demographic and clinical data from their medical records. Of 186 patients included, the mean age was 55 (SD=15); 47.5% (n=85) were female, 93% (n=173) were white, and 76.2% (n=141) were married; 60% lived at locations >10 miles from the clinic, and 58.6% had private insurance. They found:
- Between 58.4 and 74.5% of patients adhered to “aggressive” surveillance, with decreasing rates over the 5-year period.
- Annual rates of poor surveillance adherence (7.3–23.6%) increased over time.
- Based on adjusted odds ratios, patients aged <50 years, those lacking health insurance, and those with at least Stage IIB disease are more likely to be poorly adherent to melanoma surveillance.
Reserva J, Janeczek M, Joyce C, et al. A retrospective analysis of surveillance adherence of patients after treatment of primary cutaneous melanoma. 2017;10(12):44-48. J Clin Aesthet Dermatol.
This Week's Must Reads
Patients with Psoriasis and Risk Factors for PsA, Dermatol Ther (Heidelb); ePub 2018 Oct 20; Yan, et al
Ixekizumab Reduced Genital Psoriasis Symptoms, Dermatol Ther; ePub 2018 Aug 25; Beck, et al
Ixekizumab Effective, Safe for Psoriasis Treatment, J Eur Acad Dermatol Venereol; ePub 2018 Oct 14; Deza, et al
Shared Decision Making in Psoriasis Evaluated, Am J Clin Dermatol; ePub 2018 Oct 15; Larsen, et al
Psoriasis, Cardiovascular Procedure Risk Linked, J Dermatol; ePub 2018 Oct 16; Chiu, et al
Must Reads in Melanoma
Predictors of Mucosal Melanoma Survival, J Am Acad Dermatol; ePub 2018 Oct 5; Altieri, et al
Follicular Involvement Frequent in Lentigo Maligna, J Am Acad Dermatol; ePub 2018 Sep 26; Connolly, et al
Sentinel Lymph Node Positivity Markers in Melanoma, J Am Acad Dermatol; ePub 2018 Sep 18; Conic, et al
Nevus Development Trajectory from Age 3 to 16 Years, JAMA Dermatology; ePub 2018 Sep 12; Asdigian, et al
Mohs Surgery Effective for Invasive Melanomas, Dermatolog Surg; ePub 2018 Sep 7; Degesys, et al